Aspivix announces MHRA approval for Carevix device
September 2, 2024
Women are offered the opportunity to benefit from Carevix at the Peterborough City Hospital – North West Anglia NHS Foundation Trust.
Women are offered the opportunity to benefit from Carevix at the Peterborough City Hospital – North West Anglia NHS Foundation Trust.
INDIANAPOLIS, Aug. 28, 2024 /PRNewswire/ — Prevounce Health, a leading provider of remote care management software, devices, and services, announces the launch of its first blood oxygen device for remote patient monitoring (RPM): Pylo OX1-LTE.
The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.
Enovis (NYSE: ENOV)+ announced today that it unveiled its STAR Ankle system with new e+ Polyethylene.
J&J MedTech’s (NYSE: JNJ)+
DePuy Synthes unit today announced that it launched its TriLeap lower extremity anatomic plating system.
Pulse Biosciences (Nasdaq:PLSE) today announced the first completed cases in a first-in-human feasibility study of its pulsed field ablation system.
ATLANTA, Aug. 7, 2024 /PRNewswire/ — Huxley Medical, a developer of technologies that streamline cardiopulmonary care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking, chest-worn, sleep apnea diagnostic patch, SANSA.
CINCINNATI, OH August 7, 2024 – Ethicon*, a Johnson & Johnson MedTech company**, announced today that the U.S. Food & Drug Administration (FDA) has approved a label update to expand the availability of the LINX™ Reflux Management System to include patients with Barrett’s esophagus (BE) experiencing gastroesophageal reflux disease (GERD) symptoms.
Stryker (NYSE: SYK)+
announced today that it launched its Pangea plating system portfolio of devices.
Johnson & Johnson’s (NYSE: JNJ)+
DePuy Synthes announced today that it launched a dual-use robotics and standalone navigation platform that uses its Velys robot in spine surgery.